Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719653 · ClinicalTrials.gov registry record · Phase 4
A Comparison of 5 Low Volume Bowel Preparations
A Phase 4 study, sponsored by Gastroenterology Services.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,079
- Enrollment target
NCT01719653 is a Phase 4 study that has completed, run by Gastroenterology Services. The registered enrollment target is 1,079 participants.
The verdict
NCT01719653, a Phase 4 study, has completed, sponsored by Gastroenterology Services.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,079 participants
- Enrollment target
Study Summary
The purpose of this investigation is to compare 3 versions of MiraLAX/Gatorade, MoviPrep and SUPREP to see which preparation cleanses the colon best and which preparation is best tolerated.
Interventions
- DRUG MoviPrep
- OTHER Gatorade
- DRUG MiraLAX
- DRUG SUPREP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,079 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01719653
The ClinicalTrials.gov registry entry for NCT01719653 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,079 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gastroenterology Services, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which MoviPrep is the first listed.
NCT01719653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01719653 about?
NCT01719653 is a clinical study titled "A Comparison of 5 Low Volume Bowel Preparations". The purpose of this investigation is to compare 3 versions of MiraLAX/Gatorade, MoviPrep and SUPREP to see which preparation cleanses the colon best and which preparation is best tolerated.
What is the current status of trial NCT01719653?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,079 participants. The study started on 2012-10. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01719653?
The interventions under investigation include: MoviPrep (DRUG), Gatorade (OTHER), MiraLAX (DRUG), SUPREP (DRUG).
Who is sponsoring clinical trial NCT01719653?
This trial is sponsored by Gastroenterology Services, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.